| |
| |
|
| Insider
Information: |
Shaffer James P |
| Relationship: |
Chief Business Officer |
| City: |
Raleigh |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
83,321 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,083,744 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
83,321 |
|
|
| Total
Value |
$2,083,744 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Clinical Data Inc |
CLDA |
EVP & Chief Commercial... |
2011-04-12 |
0 |
|
0 |
Premium* |
|
|
Halozyme Therapeutics Inc |
HALO |
VP & Chief Commercial ... |
2014-02-04 |
54,025 |
|
0 |
Premium* |
|
|
Celladon Corp |
CLDN |
Chief Business Officer |
2021-03-12 |
29,296 |
2016-05-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
19 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CLDN |
Celladon Corp |
Chief Business Officer |
• – – |
2021-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
11,875 |
29,296 |
0 |
- |
|
| CLDN |
Celladon Corp |
Chief Business Officer |
• – – |
2020-03-05 |
4 |
A |
$7.31 |
$10,965 |
D/D |
1,500 |
15,921 |
0 |
- |
|
| CLDN |
Celladon Corp |
Chief Business Officer |
• – – |
2019-09-05 |
4 |
A |
$7.95 |
$11,921 |
D/D |
1,500 |
14,421 |
0 |
- |
|
| CLDN |
Celladon Corp |
Chief Business Officer |
• – – |
2019-03-05 |
4 |
A |
$7.95 |
$11,921 |
D/D |
1,500 |
12,921 |
0 |
- |
|
| CLDN |
Celladon Corp |
Chief Business Officer |
• – – |
2018-09-05 |
4 |
A |
$7.95 |
$11,921 |
D/D |
1,500 |
11,421 |
0 |
- |
|
| CLDN |
Celladon Corp |
Chief Business Officer |
• – – |
2018-03-05 |
4 |
A |
$8.03 |
$12,049 |
D/D |
1,500 |
9,921 |
0 |
- |
|
| CLDN |
Celladon Corp |
Chief Business Officer |
• – – |
2017-09-05 |
4 |
A |
$9.90 |
$14,854 |
D/D |
1,500 |
8,421 |
0 |
- |
|
| CLDN |
Celladon Corp |
Chief Business Officer |
• – – |
2017-03-06 |
4 |
A |
$8.20 |
$10,671 |
D/D |
1,301 |
6,921 |
0 |
- |
|
| CLDN |
Celladon Corp |
Chief Business Officer |
• – – |
2016-08-18 |
4 |
B |
$15.70 |
$49,063 |
D/D |
3,125 |
5,620 |
2.74 |
- |
|
| CLDN |
Celladon Corp |
Chief Business Officer |
• – – |
2016-06-13 |
4 |
B |
$22.16 |
$27,718 |
D/D |
1,250 |
2,495 |
2.74 |
- |
|
| CLDN |
Celladon Corp |
Chief Business Officer |
• – – |
2016-05-23 |
4 |
B |
$19.99 |
$14,893 |
D/D |
745 |
1,245 |
2.74 |
- |
|
| CLDN |
Celladon Corp |
Chief Business Officer |
• – – |
2016-05-19 |
4 |
B |
$19.52 |
$9,760 |
D/D |
500 |
500 |
2.74 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
VP & Chief Commercial Officer |
• – – |
2014-02-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,864 |
54,025 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
VP & Chief Commercial Officer |
• – – |
2014-02-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,629 |
49,161 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
VP & Chief Commercial Officer |
• – – |
2013-02-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,232 |
37,532 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
VP & Chief Commercial Officer |
• – – |
2012-11-14 |
4 |
B |
$5.22 |
$104,400 |
D/D |
20,000 |
26,300 |
2.74 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
VP, Chief Commercial OfficerOf |
• – – |
2011-12-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
6,300 |
|
- |
|
| CLDA |
Clinical Data Inc |
EVP & Chief Commercial Officer |
• – – |
2011-04-12 |
4 |
D |
$30.00 |
$30,000 |
D/D |
(1,000) |
0 |
0 |
- |
|
| CLDA |
Clinical Data Inc |
EVP & Chief Commercial Officer |
• – – |
2010-04-07 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,000 |
|
- |
|
19 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
